Amanda Elizabeth Ward

Amanda Ward practices at Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare.

Amanda Ward's NPI, 1881056067, was assigned on March 25, 2016. Amanda Ward holds Maryland license D90367.

Amanda Ward's primary practice is Greater Baltimore Medical Center, at 6701 North Charles Street, Baltimore, MD 21204 in Baltimore County. The practice phone is (443) 849-2000.

Amanda Ward's primary practice is Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare. The medical group on file is Greater Baltimore Medical Center (GBMC).

Dmand AI tracks the electronic health record (EHR) system at each site where Amanda Ward practices. Vendor and product names are available with a free account.

Hospitalist is Amanda Ward's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Amanda Ward is licensed in Maryland.

CMS data shows 956 Medicare services from Amanda Ward across 4 procedure codes in 2024, for 263 Medicare patients. Medicare paid $59,752 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 263 Medicare patients who saw Amanda Ward in 2024. The largest group is 75 to 84, with 88 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amanda Ward's median patient age at 72, with 53% women.

In 2024, Amanda Ward wrote 61 Medicare Part D claims for 27 patients. 98% of them were for generic drugs. CMS names the drug for 22 of them, across 2 drugs with 11 or more claims each, at $5,696 in total drug cost. In 2019, CMS named 39 claims across 2 drugs.

Amanda Ward accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Amanda Ward from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $14.